MGH — Boston, Massachusetts

MGH is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

MGH has participated in 33 clinical trials with 5 currently active.

Therapeutic areas: Pathology, Primary Prevention of Atherosclerotic Cardiovascular Disease, Metabolic Syndrome.

Sponsors: Philips Digital & Computational Pathology, Novartis Pharmaceuticals, Massachusetts General Hospital.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MGH?

MGH has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MGH conducted?

MGH has 33 clinical trials on record, with 5 currently active. Their work covers Pathology, Primary Prevention of Atherosclerotic Cardiovascular Disease, Metabolic Syndrome.

Is MGH accredited by Crixeo Health?

MGH has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MGH?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.